Compare NSRX & PED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NSRX | PED |
|---|---|---|
| Founded | 2019 | N/A |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.5M | 56.7M |
| IPO Year | N/A | 2012 |
| Metric | NSRX | PED |
|---|---|---|
| Price | $5.06 | $0.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $20.50 | $1.50 |
| AVG Volume (30 Days) | 2.3K | ★ 147.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $39,553,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $305.89 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 28.49 |
| 52 Week Low | $4.90 | $0.43 |
| 52 Week High | $9.99 | $0.82 |
| Indicator | NSRX | PED |
|---|---|---|
| Relative Strength Index (RSI) | 44.19 | 54.93 |
| Support Level | N/A | $0.57 |
| Resistance Level | $6.39 | $0.67 |
| Average True Range (ATR) | 0.74 | 0.03 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 30.57 | 39.06 |
Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.